Definitive Contract HHSN272201700079C
Award Date
7/27/17
Potential Completion Date
1/31/19
Potential Value
$300K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Aphios Corp
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Woburn, MA 01801, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
<p>The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $224,881.00 Firm Fixed Price contract to Keystone Nano Inc., a Small Disadvantaged Business, for the "DEVELOPMENT OF SIRNA NANOJACKETS FOR RNAI-BASED INFLUENZA TREATMENT" under the Small Business Innovation Research (SBIR) Program Phase I. The contract has a completion date of January 31, 2017. This award is a Definitive Contract and is set aside for small business.</p>
This is a $94,448 firm fixed price contract awarded by the National Center for Complementary and Integrative Health, a component of the U.S. Department of Health and Human Services, to Aphios Corp, a minority-owned small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for research and development work related to the NCCAM 002 SBIR Phase I topic. The award has a total small business set-aside designation, and the contract's ultimate completion date...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Small Business Innovation Research (SBIR) Program Phase I contract to Mirecule, Inc., a self-certified small disadvantaged business, to develop chemically modified mimics of microRNAs with improved activity and stability for the treatment of many diseases. The contract has a firm fixed price of $305,000.00 and a completion date of December 31, 2019. The...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Acousticabio, Inc., a small business in Cambridge, MA. The contract, valued at $295,116, is for the development of "HIGH-DOSE AND SUSTAINED DELIVERY OF HIV-1 BROADLY NEUTRALIZING ANTIBODIES VIA SUBCUTANEOUS INJECTION OF HYDROGEL-BASED MICROPARTICLE FORMATIONS". This contract is...
This is a $600,000.00 Firm Fixed Price contract awarded by the National Institutes of Health (NIH), part of the Department of Health and Human Services (HHS), to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The objective is to develop an effective human immunodeficiency virus (HIV) vaccine using engineered nanoparticles loaded with messenger RNA (mRNA) targeted to antigen presenting cells. This contract is part of the Small Business Innovation Research (SBIR)...
The U.S. government agency awarded a Small Business Innovation Research (SBIR) Program Phase I action contract to Aphios Corp, a minority-owned for-profit organization, for the development of anticancer agents. The fixed-price contract, valued at $149,558.00, was awarded on September 30, 2008, with a completion date of May 31, 2009. The contract was a result of a request for proposal (RFP) titled "DEVELOPMENT OF ANTICANCER AGENTS" and was assigned the solicitation number...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Definitive Contract to Ai Biosciences, Inc., a minority-owned, self-certified small disadvantaged business, for the development of a low-cost, automated, and rapid home HIV viral load test. The award, which is part of the Small Business Innovation Research (SBIR) Program Phase I, has a potential value of $294,538.00 and a completion date of...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $300,000 definitive contract to Antagen Biosciences Inc., doing business as Antagen Pharmaceuticals, as part of the Small Business Innovation Research Program Phase I Action. The contract is a firm fixed price award with a period of performance from July 5, 2022 through November 30, 2023 to be performed in Canton, Massachusetts. The award is set aside for...
This is a $1,500,000.00 Small Business Innovation Research (SBIR) Phase II contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the Department of Health and Human Services, to Cure Systems LLC, a self-certified small disadvantaged business located in Newton, Massachusetts. The contract is for the research and development of "Vector-Based Delivery of HIV Broadly Neutralizing Antibodies," a specialized approach to developing advanced...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) awarded a $298,596 definitive contract to Sanaria Inc. of Potomac, MD for Research Type Small Business Innovation Research Program Phase I Action. The contract is a firm fixed price award with a period of performance from August 30, 2022 through April 1, 2024. The place of performance is Potomac, MD and the contract has a total small business set aside...